Q32 Bio shares their experience with Magnephy

We are very excited to share a recent testimonial from the Preclinical Research and Translational Biology team, at Q32 Bio, who have utilized Magnephy’s nanoscale microscopy solution to gain new insights. Q32 Bio is a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and severe inflammatory diseases. 

Everyone in the Magnephy team were very happy to receive such a glowing testimonial. The collaboration with Q32 Bio has been one of shared enthusiasm and we are very much looking forward to our continued collaboration in the future! 


Curious how Magnephy could support your research?
Contact us today to explore the potential of nanoscale 3D imaging in your development pipeline!